DLH Holdings [DLHC] vs Lichen China [LICN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: DLH Holdings Corp. wins in 10 metrics, Lichen China Ltd. wins in 7 metrics, with 0 ties. DLH Holdings Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric DLH Holdings Corp. Lichen China Ltd. Better
P/E Ratio (TTM) 64.89 0.06 Lichen China Ltd.
Price-to-Book Ratio 0.78 0.08 Lichen China Ltd.
Debt-to-Equity Ratio 133.53 0.56 Lichen China Ltd.
PEG Ratio -0.31 N/A N/A
EV/EBITDA 7.96 1.66 Lichen China Ltd.
Profit Margin (TTM) -0.33% -43.20% DLH Holdings Corp.
Operating Margin (TTM) 2.08% -36.80% DLH Holdings Corp.
EBITDA Margin (TTM) 2.08% N/A N/A
Return on Equity -0.96% -23.98% DLH Holdings Corp.
Return on Assets (TTM) 2.59% -10.28% DLH Holdings Corp.
Free Cash Flow (TTM) $22.98M $-11.51M DLH Holdings Corp.
1-Year Return 12.20% -68.90% DLH Holdings Corp.
Price-to-Sales Ratio (TTM) 0.27 2.78 DLH Holdings Corp.
Enterprise Value $236.79M $-17.34M DLH Holdings Corp.
EV/Revenue Ratio 0.73 -0.46 DLH Holdings Corp.
Gross Profit Margin (TTM) 19.59% N/A N/A
Revenue per Share (TTM) $22 $162 Lichen China Ltd.
Earnings per Share (Diluted) $-0.08 $-71.76 DLH Holdings Corp.
Beta (Stock Volatility) 1.58 -0.47 Lichen China Ltd.
Short % of Float 0.85% 0.23% Lichen China Ltd.

DLH Holdings Corp. vs Lichen China Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
DLH Holdings Corp.0.18%-1.61%-2.65%-6.77%-12.26%-1.25%
Lichen China Ltd.5.92%36.44%-62.30%-48.89%-46.15%-44.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
DLH Holdings Corp.12.20%-50.40%-54.39%15.91%359.84%-19.40%
Lichen China Ltd.-68.90%-19.05%-62.68%-62.68%-62.68%-62.68%

Performance & Financial Health Analysis: DLH Holdings Corp. vs Lichen China Ltd.

MetricDLHCLICN
Market Information
Market Cap i$87.25M$98.78M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i8,24042,610
90 Day Avg. Volume i8,31357,957
Last Close$5.51$1.61
52 Week Range$5.10 - $8.10$0.75 - $9.49
% from 52W High-31.98%-83.04%
All-Time High$98.88 (May 13, 1996)$18.00 (Feb 17, 2025)
% from All-Time High-94.43%-91.06%
Growth Metrics
Quarterly Revenue Growth-0.24%-0.21%
Quarterly Earnings Growth-0.24%N/A
Financial Health
Profit Margin (TTM) i0.00%-0.43%
Operating Margin (TTM) i0.02%-0.37%
Return on Equity (TTM) i-0.01%-0.24%
Debt to Equity (MRQ) i133.530.56
Cash & Liquidity
Book Value per Share (MRQ)$7.74$84.34
Cash per Share (MRQ)$0.02$29.63
Operating Cash Flow (TTM) i$29.98M$-11,113,000
Levered Free Cash Flow (TTM) i$33.87M$540,200
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: DLH Holdings Corp. vs Lichen China Ltd.

MetricDLHC (Apr 26, 2026)LICN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i64.890.06
Forward P/E i-21.50N/A
PEG Ratio i-0.31N/A
Price to Sales (TTM) i0.272.78
Price to Book (MRQ) i0.780.08
Market Capitalization
Market Capitalization i$87.25M$98.78M
Enterprise Value i$236.79M$-17,340,320
Enterprise Value Metrics
Enterprise to Revenue i0.73-0.46
Enterprise to EBITDA i7.961.66
Risk & Other Metrics
Beta i1.58-0.47
Book Value per Share (MRQ) i$7.74$84.34

Financial Statements Comparison: DLH Holdings Corp. vs Lichen China Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDLHC (2025)LICN (2024)
Revenue/Sales i344.50M41.48M
Cost of Goods Sold i279.33M15.80M
COGS % of Revenue i81.1%38.1%
Gross Profit i65.16M25.67M
Gross Margin i18.9%61.9%
Research & Development iN/AN/A
Operating Income (EBIT) i16.79M-4.55M
Operating Margin i4.9%-11.0%
EBITDA i32.29M-1.68M
EBITDA Margin i9.4%-4.0%
Pre-Tax Income i1.76M-4.17M
Pre-Tax Income % of Revenue i0.5%-10.1%
Income Tax i393,0001.95M
Income Tax % of Revenue i0.1%4.7%
Net Income (Profit) i1.36M-6.12M
Profit Margin i0.4%-14.8%

Balance Sheet & Liquidity Metrics

MetricDLHC (2025)LICN (2024)
Cash & Equivalents i125,00026.71M
Total Current Assets i42.54M34.01M
Total Current Assets % of Revenue i12.3%82.0%
Total Current Liabilities i42.67M4.27M
Total Current Liabilities % of Revenue i12.4%10.3%
Long-Term Debt i133.99M5,000
Long-Term Debt % of Revenue i38.9%0.0%
Total Shareholders Equity i112.96M75.57M
Retained Earnings i11.21M42.08M
Retained Earnings % of Revenue i3.3%101.5%
Property, Plant & Equipment i8.76M61,000

Cash Flow Statement Comparison

MetricDLHC (2025)LICN (2024)
Operating Cash Flow i23.91M493,000
Operating Cash Flow % of Revenue i6.9%1.2%
Capital Expenditures i-241,000-36,000
Free Cash Flow i22.98M-11.51M
FCF Margin i6.7%-27.7%
Debt Repayment i-276.17M0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDLHCLICN
Shares Short i53,91437,368
Short Ratio i6.680.86
Short % of Float i0.85%0.23%
Shares Outstanding i14.49M761,825
Float Shares i6.33M756,690
% Held by Insiders i12.42%0.00%
% Held by Institutions i68.45%0.00%
% Held by Public i19.13%100.00%

Dividend Analysis & Yield Comparison: DLH Holdings Corp. vs Lichen China Ltd.

MetricDLHCLICN
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A